Gadolinium Contrast Agent Deposition in Children

Overview

Journal J Magn Reson Imaging

Date 2024 Apr 10

PMID 38597340

Authors

Minglei Ouyang

Li Bao

Affiliations

Soon will be listed here.

Abstract

Over the past few years, a large number of studies have evidenced increased signal intensity in the deep brain nuclei on unenhanced T1-MRI images achieved by the application of gadolinium-based contrast agents (GBCAs). The deposition of gadolinium in the brain, bone, and other tissues following administration of GBCAs has also been confirmed in histological studies in rodents and in necropsy studies in adults and children. Given the distinct physiological characteristics of children, this review focuses on examining the current research on gadolinium deposition in children, particularly studies utilizing novel methods and technologies. Furthermore, the article compares safety research findings of linear GBCAs and macrocyclic GBCAs in children, with the aim of offering clinicians practical guidance based on the most recent research outcomes. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 2.

References

Kanda T, Nakai Y, Oba H, Toyoda K, Kitajima K, Furui S . Gadolinium deposition in the brain. Magn Reson Imaging. 2016; 34(10):1346-1350. DOI: 10.1016/j.mri.2016.08.024. View

Gulino P, Bianchi A, Diciotti S, Scionti A, Sali L, Papadopulos P . The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population. Acta Radiol. 2020; 62(3):368-376. DOI: 10.1177/0284185120927920. View

Mathur M, Jones J, Weinreb J . Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist's Primer. Radiographics. 2019; 40(1):153-162. DOI: 10.1148/rg.2020190110. View

Tamrazi B, Liu C, Cen S, Nelson M, Dhall G, Nelson M . Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity. Radiology. 2018; 289(1):188-194. DOI: 10.1148/radiol.2018173057. View

Ozturk K, Nascene D . Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol. 2021; 42(6):1136-1143. PMC: 8191654. DOI: 10.3174/ajnr.A7143. View

Layne K, Dargan P, Archer J, Wood D . Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents. Br J Clin Pharmacol. 2018; 84(11):2522-2534. PMC: 6177715. DOI: 10.1111/bcp.13718. View

Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D . High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014; 270(3):834-41. DOI: 10.1148/radiol.13131669. View

Choi Y, Jang J, Kim J, Nam Y, Shin N, Ahn K . MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study. Radiology. 2020; 297(1):143-150. DOI: 10.1148/radiol.2020192579. View

Tibussek D, Rademacher C, Caspers J, Turowski B, Schaper J, Antoch G . Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study. Radiology. 2017; 285(1):223-230. DOI: 10.1148/radiol.2017161151. View

10.

Young J, Qiao J, Orosz I, Salamon N, Franke M, Kim H . Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol. Eur Radiol. 2018; 28(11):4882-4889. PMC: 6226378. DOI: 10.1007/s00330-018-5464-5. View

11.

Wang C, Asch D, Cavallo J, Dillman J, Ellis J, Forbes-Amrhein M . Statement from the ACR Committee on Drugs and Contrast Media on the Intravenous Iodinated Contrast Media Shortage. J Am Coll Radiol. 2022; 19(7):834-835. DOI: 10.1016/j.jacr.2022.05.006. View

12.

Kasper E, Schemuth H, Horry S, Kinner S . Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent. Pediatr Radiol. 2018; 48(5):686-693. DOI: 10.1007/s00247-018-4080-5. View

13.

McDonald J, McDonald R, Jentoft M, Paolini M, Murray D, Kallmes D . Intracranial Gadolinium Deposition Following Gadodiamide-Enhanced Magnetic Resonance Imaging in Pediatric Patients: A Case-Control Study. JAMA Pediatr. 2017; 171(7):705-707. PMC: 6583486. DOI: 10.1001/jamapediatrics.2017.0264. View

14.

Towbin A, Zhang B, Dillman J . A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal. Pediatr Radiol. 2021; 51(3):457-470. DOI: 10.1007/s00247-020-04860-5. View

15.

Schneider G, Stroeder J, Roditi G, Colosimo C, Armstrong P, Martucci M . T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease. AJNR Am J Neuroradiol. 2017; 38(9):1799-1806. PMC: 7963691. DOI: 10.3174/ajnr.A5270. View

16.

Gianolio E, Bardini P, Arena F, Stefania R, Di Gregorio E, Iani R . Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents. Radiology. 2017; 285(3):839-849. DOI: 10.1148/radiol.2017162857. View

17.

Raczeck P, Fries P, Bucker A, Schneider G . [Gadolinium deposition-"gadolinium deposition disease"]. Radiologe. 2019; 59(5):435-443. DOI: 10.1007/s00117-019-0522-9. View

18.

Grobner T . Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant. 2006; 21(4):1104-8. DOI: 10.1093/ndt/gfk062. View

19.

Bussi S, Coppo A, Celeste R, Fanizzi A, Fringuello Mingo A, Ferraris A . Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats. Insights Imaging. 2020; 11(1):11. PMC: 7000570. DOI: 10.1186/s13244-019-0824-5. View

20.

Darrah T, Prutsman-Pfeiffer J, Poreda R, Campbell M, Hauschka P, Hannigan R . Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics. 2011; 1(6):479-88. DOI: 10.1039/b905145g. View